相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study
Rowmika Ravi et al.
METABOLITES (2022)
Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure
Hidemichi Kouzu et al.
ESC HEART FAILURE (2022)
Difference in Metabolomic Response to Exercise between Patients with and without Hypertrophic Cardiomyopathy
Yuichi J. Shimada et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy
Sara Ranjbarvaziri et al.
CIRCULATION (2021)
BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants-design and status
M. Jansen et al.
NETHERLANDS HEART JOURNAL (2021)
Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
Maike Schuldt et al.
CELLS (2021)
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
Martino Deidda et al.
METABOLITES (2021)
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
J. Pei et al.
CLINICAL EPIGENETICS (2021)
Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure
Hidemichi Kouzu et al.
ESC HEART FAILURE (2021)
Metabolic Profiling Associates with Disease Severity in Nonischemic Dilated Cardiomyopathy
Job A. J Verdonschot et al.
JOURNAL OF CARDIAC FAILURE (2020)
U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
Ziqiong Wang et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2020)
Metabolomic signatures of cardiac remodelling and heart failure risk in the community
Charlotte Andersson et al.
ESC HEART FAILURE (2020)
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Wei Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Sex differences in hypertrophic cardiomyopathy: new insights
Beau van Driel et al.
CURRENT OPINION IN CARDIOLOGY (2019)
Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
Larissa M. Dorsch et al.
CELLS (2019)
Direct Infusion Based Metabolomics Identifies Metabolic Disease in Patients' Dried Blood Spots and Plasma
Hanneke A. Haijes et al.
METABOLITES (2019)
HMDB 4.0: the human metabolome database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Jolanda van der Velden et al.
CARDIOVASCULAR RESEARCH (2018)
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du et al.
THERANOSTICS (2018)
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
Ara Koh et al.
CELL (2018)
MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
James W. McNamara et al.
PLOS ONE (2017)
Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond
Matthieu Ruiz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Disease Stage-Dependent Changes in Cardiac Contractile Performance and Oxygen Utilization Underlie Reduced Myocardial Efficiency in Human Inherited Hypertrophic Cardiomyopathy
Ahmet Guclu et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2017)
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk The MESA Study
Peter J. Leary et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
John R. Ussher et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy
Ling Zhu et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: A preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation
Youzhou Chen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy
Benedicte Jorgenrud et al.
PLOS ONE (2015)
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Constantinos O'Mahony et al.
EUROPEAN HEART JOURNAL (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
2-Aminoadipic acid is a biomarker for diabetes risk
Thomas J. Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy
Saskia Schlossarek et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Mortality Risk of Untreated Myosin-Binding Protein C-Related Hypertrophic Cardiomyopathy Insight Into the Natural History
Eline A. Nannenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening
Imke Christiaans et al.
EUROPEAN HEART JOURNAL (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands
I. Christiaans et al.
NETHERLANDS HEART JOURNAL (2010)
Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction
Sabine J. van Dijk et al.
CIRCULATION (2009)
Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice
Simona Vittorini et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Building Predictive Models in R Using the caret Package
Max Kuhn
JOURNAL OF STATISTICAL SOFTWARE (2008)
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies
Jiyoong Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
P Richard et al.
CIRCULATION (2003)
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure
JJ Hwang et al.
PHYSIOLOGICAL GENOMICS (2002)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
